Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference-Reference-Cited by-同舟云学术

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Published:2017-12 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Liu Qing-Rong,Canseco-Alba Ana,Zhang Hai-Ying,Tagliaferro Patricia,Chung Monika,Dennis Eugene,Sanabria Branden,Schanz Norman,Escosteguy-Neto Joao Carlos,Ishiguro Hiroki,Lin Zhicheng,Sgro Susan,Leonard Claire M.,Santos-Junior Jair Guilherme,Gardner Eliot L.,Egan Josephine M.,Lee Jeung Woon,Xi Zheng-Xiong,Onaivi Emmanuel S.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-17796-y.pdf

Reference69 articles.

1. Onaivi, E. S. et al. CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J. Psychopharmacol 26, 92–103 (2012).

2. Marsicano, G. et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84–88 (2003).

3. Monory, K. et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455–466 (2006).

4. Albayram, O. et al. Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. PNAS 108, 11256–11261 (2011).

5. Zhang, H. Y. et al. Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats. Neuropsychopharmacol 40, 1037–51 (2015).

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotine-induced transcriptional changes and mitochondrial dysfunction in the ventral tegmental area revealed by single-nucleus transcriptomics;Journal of Genetics and Genomics;2024-09

2. CB2 expression in mouse brain: from mapping to regulation in microglia under inflammatory conditions;Journal of Neuroinflammation;2024-08-19

3. JWH-182: a safe and effective synthetic cannabinoid for chemotherapy-induced neuropathic pain in preclinical models;Scientific Reports;2024-07-15

4. Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-03

5. Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety;European Journal of Medicinal Chemistry;2024-02